相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The preclinical discovery and development of rectal artesunate for the treatment of malaria in young children; review of evidence
Lais Pessanha de Carvalho et al.
EXPERT OPINION ON DRUG DISCOVERY (2021)
A Kelch13-defined endocytosis pathway mediates artemisinin resistance in malaria parasites
Jakob Birnbaum et al.
SCIENCE (2020)
Xiaozhang Tie Improves Intestinal Motility in Rats With Cirrhotic Ascites by Regulating the Stem Cell Factor/c-kit Pathway in Interstitial Cells of Cajal
Qiang Zhao et al.
FRONTIERS IN PHARMACOLOGY (2020)
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial
Rob W. van der Pluijm et al.
LANCET (2020)
Characterization of putative drug resistant biomarkers inPlasmodium falciparumisolated from Ghanaian blood donors
Enoch Aninagyei et al.
BMC INFECTIOUS DISEASES (2020)
Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study
Mallika Imwong et al.
LANCET INFECTIOUS DISEASES (2020)
Lipid Compositions in Infant Formulas Affect the Solubilization of Antimalarial Drugs Artefenomel (OZ439) and Ferroquine during Digestion
Malinda Salim et al.
MOLECULAR PHARMACEUTICS (2020)
Emergence and clonal expansion of in vitro artemisinin-resistantPlasmodium falciparum kelch13R561H mutant parasites in Rwanda
Aline Uwimana et al.
NATURE MEDICINE (2020)
Analysis of Plasmodium falciparum Na+/H+ exchanger (pfnhe1) polymorphisms among imported African malaria parasites isolated in Wuhan, Central China
Kai Wu et al.
BMC INFECTIOUS DISEASES (2019)
Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study
William L. Hamilton et al.
LANCET INFECTIOUS DISEASES (2019)
Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study
Rob W. van der Pluijm et al.
LANCET INFECTIOUS DISEASES (2019)
Decreased K13 Abundance Reduces Hemoglobin Catabolism and Proteotoxic Stress, Underpinning Artemisinin Resistance
Tuo Yang et al.
CELL REPORTS (2019)
Monitoring of efficacy, tolerability and safety of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambarene, Gabon: an open-label clinical trial
Bayode R. Adegbite et al.
MALARIA JOURNAL (2019)
Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria
Joseph Pryce et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2019)
Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis
Henry M. Staines et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial
Issaka Sagara et al.
LANCET (2018)
A phase 1 evaluation of the pharmacokinetic/pharmacodynamic interaction of the anti-malarial agents KAF156 and piperaquine
F. Joel Leong et al.
MALARIA JOURNAL (2018)
Resistance screening and trend analysis of imported falciparum malaria in NSW, Australia ( 2010 to 2016)
Christiane Prosser et al.
PLOS ONE (2018)
Plasmepsin II-III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum
Selina Bopp et al.
NATURE COMMUNICATIONS (2018)
The early preclinical and clinical development of ganaplacide (KAF156), a novel antimalarial compound
Robin Koller et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2018)
Structure-Activity Relationship of the Antimalarial Ozonide Artefenomel (OZ439)
Yuxiang Dong et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Quantification of the antimalarial drug pyronaridine in whole blood using LC-MS/MS Increased sensitivity resulting from reduced non-specific binding
Daniel Blessborn et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2017)
Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam
Ngo Viet Thanh et al.
MALARIA JOURNAL (2017)
Phase 2a, Open-Label, 4-Escalating-Dose, Randomized Multicenter Study Evaluating the Safety and Activity of Ferroquine (SSR97193) Plus Artesunate, versus Amodiaquine Plus Artesunate, in African Adult Men with Uncomplicated Plasmodium falciparum Malaria
Christian Supan et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2017)
The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread
Charles J. Woodrow et al.
FEMS MICROBIOLOGY REVIEWS (2017)
Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam
Bui Quang Phuc et al.
EMERGING INFECTIOUS DISEASES (2017)
Independent Emergence of the Plasmodium falciparum Kelch Propeller Domain Mutant Allele C580Y in Guyana
Stella M. Chenet et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Efficacy and Safety of Pyronaridine-Artesunate for Treatment of Uncomplicated Plasmodium falciparum Malaria in Western Cambodia
Rithea Leang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Declining Efficacy of Artemisinin Combination Therapy Against P. Falciparum Malaria on the Thai-Myanmar Border (2003-2013): The Role of Parasite Genetic Factors
Aung Pyae Phyo et al.
CLINICAL INFECTIOUS DISEASES (2016)
Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study
Chanaki Amaratunga et al.
LANCET INFECTIOUS DISEASES (2016)
Antimalarial Activity of KAF156 in Falciparum and Vivax Malaria
Nicholas J. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Parasites resistant to the antimalarial atovaquone fail to transmit by mosquitoes
Christopher D. Goodman et al.
SCIENCE (2016)
Intramuscular Artesunate for Severe Malaria in African Children: A Multicenter Randomized Controlled Trial
Peter G. Kremsner et al.
PLOS MEDICINE (2016)
The molecular basis of antifolate resistance in Plasmodium falciparum: looking beyond point mutations
Adina Heinberg et al.
MALARIA: ADVANCES IN PATHOPHYSIOLOGY, BIOLOGY, AND DRUG DEVELOPMENT (2015)
Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment
Rithea Leang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Fosmidomycin as an antimalarial drug: a meta-analysis of clinical trials
Jose Francisco Fernandes et al.
FUTURE MICROBIOLOGY (2015)
Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study
Jana Held et al.
LANCET INFECTIOUS DISEASES (2015)
Independent Emergence of Artemisinin Resistance Mutations Among Plasmodium falciparum in Southeast Asia
Shannon Takala-Harrison et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Emergence of Resistance to Atovaquone-Proguanil in Malaria Parasites: Insights from Computational Modeling and Clinical Case Reports
Gilles Cottrell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Imidazolopiperazine KAF156 To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers
F. Joel Leong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Delayed Hemolysis After Treatment With Parenteral Artesunate in African Children With Severe Malaria-A Double-center Prospective Study
Thierry Rolling et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Randomized Trial of Artesunate-Amodiaquine, Atovaquone-Proguanil, and Artesunate-Atovaquone-Proguanil for the Treatment of Uncomplicated Falciparum Malaria in Children
Rachida Tahar et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Frederic Ariey et al.
NATURE (2014)
Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system
Mehdi Ghorbal et al.
NATURE BIOTECHNOLOGY (2014)
The Origins of Antimalarial-Drug Resistance
Randall M. Packard
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
E. A. Ashley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Spiroindolone KAE609 for Falciparum and Vivax Malaria
Nicholas J. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Dihydroartemisinin-Piperaquine Failure in Cambodia
David L. Saunders et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Fixed dose combination of arterolane and piperaquine: A newer prospect in antimalarial therapy
C. Y. Patil et al.
ANNALS OF MEDICAL AND HEALTH SCIENCES RESEARCH (2014)
Trends in Antimalarial Drug Use in Africa
Jennifer A. Flegg et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2013)
Antimalarial pharmacology and therapeutics of atovaquone
Gemma L. Nixon et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies
Benoit Witkowski et al.
LANCET INFECTIOUS DISEASES (2013)
Identification of resistance of Plasmodium falciparum to artesunate-mefloquine combination in an area along the Thai-Myanmar border: integration of clinico-parasitological response, systemic drug exposure, and in vitro parasite sensitivity
Kesara Na-Bangchang et al.
MALARIA JOURNAL (2013)
Evidence of an increased incidence of day 3 parasitaemia in Suriname: an indicator of the emerging resistance of Plasmodium falciparum to artemether
Stephen G. S. Vreden et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2013)
Antidogmatic approaches to artemisinin resistance: reappraisal as treatment failure with artemisinin combination therapy
Sanjeev Krishna et al.
TRENDS IN PARASITOLOGY (2013)
Imidazolopiperazines: Lead Optimization of the Second-Generation Antimalarial Agents
Advait Nagle et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study
Aung Pyae Phyo et al.
LANCET (2012)
Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study
Chanaki Amaratunga et al.
LANCET INFECTIOUS DISEASES (2012)
Review of pyronaridine anti-malarial properties and product characteristics
Simon L. Croft et al.
MALARIA JOURNAL (2012)
Pyronaridine-Artesunate versus Mefloquine plus Artesunate for Malaria
Ronnatrai Rueangweerayut et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Focused Screening and Treatment (FSAT): A PCR-Based Strategy to Detect Malaria Parasite Carriers and Contain Drug Resistant P. falciparum, Pailin, Cambodia
Stefan Hoyer et al.
PLOS ONE (2012)
In vitro amodiaquine resistance and its association with mutations in pfcrt and pfmdr1 genes of Plasmodium falciparum isolates from Nigeria
O. A. Folarin et al.
ACTA TROPICA (2011)
A Second Target of the Antimalarial and Antibacterial Agent Fosmidomycin Revealed by Cellular Metabolic Profiling
Baichen Zhang et al.
BIOCHEMISTRY (2011)
THE ANTIMALARIAL FERROQUINE: FROM BENCH TO CLINIC
C. Biot et al.
PARASITE (2011)
Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria
Susan A. Charman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Exploring the Contribution of Candidate Genes to Artemisinin Resistance in Plasmodium falciparum
Mallika Imwong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai-Myanmar border
Kesara Na-Bangchang et al.
MALARIA JOURNAL (2010)
Spiroindolones, a Potent Compound Class for the Treatment of Malaria
Matthias Rottmann et al.
SCIENCE (2010)
Artemisinin Resistance in Plasmodium falciparum Malaria.
Arjen M. Dondorp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial
Jane Achan et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon
Michael Ramharter et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Evidence of Artemisinin-Resistant Malaria in Western Cambodia
Harald Noedl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
In vitro monitoring of Plasmodium falciparum drug resistance in French Guiana: a synopsis of continuous assessment from 1994 to 2005
Eric Legrand et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Pyrimethamine-resistant dihydrofolate reductase enzymes of Plasmodium falciparum are not enzymatically compromised in vitro
Conner I. Sandefur et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2007)
In vitro activity of ferroquine (SSR 97193) against Plasmodium falciparum isolates from the Thai-Burmese border
Marion Barends et al.
MALARIA JOURNAL (2007)
Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria
Sunny Oyakhirome et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
In vitro antimalarial drug susceptibility and pfcrt mutation among fresh Plasmodium falciparum isolates from the Lao PDR (Laos)
Mayfong Mayxay et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2007)
In vitro activity of ferroquine (SAR97193) is independent of chloroquine resistance in Plasmodium falciparum
Andrea Kreidenweiss et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2006)
Tetracyclines specifically target the picoplast of the malaria parasite Plasmodium falciparum
Erica L. Dahl et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malaria
Steffen Borrmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
In-vitro susceptibility of Plasmodium falciparum to monodesethylamodiaquine, dihydroartemisinin and quinine in an area of high chloroquine resistance in Rwanda
H Tinto et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2006)
Successful treatment of Plasmodium falciparum malaria with a six-dose regimen of artemether-lumefantrine versus quinine-doxycycline in the western Amazon region of Brazil
MG Alecrim et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2006)
Quinine for the treatment of uncomplicated Plasmodium falciparum malaria in eastern Sudan
I Adam et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2005)
Short-course regimens of artesunate-fosmidomycin in treatment of uncomplicated Plasmodium falciparum malaria
S Borrmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria:: A randomized controlled trial
M Ramharter et al.
CLINICAL INFECTIOUS DISEASES (2005)
Insights into the mechanism of action of ferroquine. Relationship between physicochemical properties and antiplasmodial activity
Christophe Biot et al.
MOLECULAR PHARMACEUTICS (2005)
Atovaquone and proguanil versus amodiaquine for the treatment of plasmodium falciparum malaria in African infants and young children
S Borrmann et al.
CLINICAL INFECTIOUS DISEASES (2003)
In vitro and in vivo synergy of fosmidomycin, a novel antimalarial drug, with clindamycin
J Wiesner et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Clindamycin as an antimalarial drug: Review of clinical trials
B Lell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Mutations in the P-falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance
DA Fidock et al.
MOLECULAR CELL (2000)
分享论文
